Commentary
The aftermath of the Merck's HIV vaccine trial
-
* Corresponding author: Giuseppe Scala scala@dbbm.unina.it
- † Equal contributors
Retrovirology 2008, 5:56 doi:10.1186/1742-4690-5-56
No comments have yet been made on this article.